2022
Post-9/11 deployment history and the incidence of breast cancer among women veterans
Gaffey A, Han L, Ramsey C, Skanderson M, Dziura J, Driscoll M, Burg M, Brandt C, Bastian L, Haskell S. Post-9/11 deployment history and the incidence of breast cancer among women veterans. Annals Of Epidemiology 2022, 77: 98-102. PMID: 36470323, DOI: 10.1016/j.annepidem.2022.11.010.Peer-Reviewed Original ResearchConceptsOEF/OIF deploymentBreast cancerWomen veteransHealthcare utilizationHormone replacement therapy useRetrospective cohort studyVeterans Affairs (VA) careHealthy soldier effectOEF/OIFCohort studyTherapy useBC incidenceHormonal contraceptivesLifestyle factorsPrimary careBC diagnosisLower incidenceOperations Enduring Freedom/Iraqi FreedomWomenIncidenceGreater likelihoodIraqi FreedomVeteransCancerCare
1995
Cytologic screening after hysterectomy for benign disease
Piscitelli J, Bastian L, Wilkes A, Simel D. Cytologic screening after hysterectomy for benign disease. American Journal Of Obstetrics And Gynecology 1995, 173: 424-432. PMID: 7645617, DOI: 10.1016/0002-9378(95)90262-7.Peer-Reviewed Original ResearchConceptsBenign diseaseCytologic abnormalitiesVaginal dysplasiaInvasive gynecologic malignancyLow-risk patientsAbnormal cytology resultsCervical cytologic abnormalitiesProportional hazards regressionKaplan-Meier estimatesLittle clinical significanceMain outcome variablesTrue positive casesGynecologic malignanciesRetrospective cohortHazards regressionCytology resultsCytology testDysplasia casesClinical significanceLower incidencePositive casesPatientsScreening testHysterectomyOutcome variables